155
Views
64
CrossRef citations to date
0
Altmetric
Original Research

Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders

, , , , &
Pages 139-148 | Published online: 11 Feb 2013

References

  • PerryHDDry eye disease: pathophysiology, classification, and diagnosisAm J Manag Care200814Suppl 3S79S8718452371
  • de TavaresFPFernandesRSBernardesTFBonfioliAASoaresEJDry eye diseaseSemin Ophthalmol2010253849320590418
  • LabbéABrignole-BaudouinFBaudouinCOcular surface investigations in dry eyeJ Fr Ophtalmol20073017697 French17287676
  • ScheinODMuñozBTielschJMBandeen-RocheKWestSPrevalence of dry eye among the elderlyAm J Ophthalmol199712467237289402817
  • MuñozBWestSKRubinGSCauses of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation StudyArch Ophthalmol2000118681982510865321
  • MossSEKleinRKleinBELong-term incidence of dry eye in an older populationOptom Vis Sci200885866867418677233
  • SchaumbergDASullivanDABuringJEDanaMRPrevalence of dry eye syndrome among US womenAm J Ophthalmol2003136231832612888056
  • GipsonIKSpurr-MichaudSArgüesoPTisdaleANgTFRussoCLMucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell linesInvest Ophthalmol Vis Sci20034462496250612766048
  • BaudouinCA new approach for better comprehension of diseases of the ocular surfaceJ Fr Ophtalmol2007303239246 French17417148
  • VanDerMeidKRSuSPKrenzerKLWardKWZhangJZA method to extract cytokines and matrix metalloproteinases from Schirmer strips and analyze using LuminexMol Vis2011171056106321552500
  • Enríquez-de-SalamancaACastellanosESternMETear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye diseaseMol Vis20101686287320508732
  • BaudouinCBrignoleFBecquetFPisellaPJGoguelAFlow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammationInvest Ophthalmol Vis Sci1997387145814649191610
  • VignaliDAMultiplexed particle-based flow cytometric assaysJ Immunol Methods20002431–224325510986418
  • MassingaleMLLiXVallabhajosyulaMChenDWeiYAsbellPAAnalysis of inflammatory cytokines in the tears of dry eye patientsCornea20092891023102719724208
  • HalliwellBFree radicals and antioxidants: updating a personal viewNutr Rev201270525726522537212
  • Zanon-MorenoVMarco-VenturaPLleo-PerezAVOxidative stress in primary open-angle glaucomaJ Glaucoma200817426326818552610
  • BerthoudVMBeyerECOxidative stress, lens gap junctions, and cataractsAntioxid Redox Signal200911233935318831679
  • Garcia-MedinaJJPinazo-DuranMDGarcia-MedinaMZanon-MorenoVPons-VazquezSA 5-year follow-up of antioxidant supplementation in type 2 diabetic retinopathyEur J Ophthalmol201121563764321218388
  • SuzukiMTsujikawaMItabeHChronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degenerationJ Cell Sci2012125Pt 102407241522357958
  • VenkataSJNarayanasamyASrinivasanVTear ascorbic acid levels and the total antioxidant status in contact lens wearers: a pilot studyIndian J Ophthalmol200957428929219574697
  • Pinazo-DuránMDZanón-MorenoVGarcía-MedinaJJGallego-PinazoREvaluation of presumptive biomarkers of oxidative stress, immune response and apoptosis in primary open-angle glaucomaCurr Opin Pharmacol20121319810723142105
  • MedzhitovRJanewayCJrInnate immunityN Engl J Med2000343433834410922424
  • ZoukhriDEffect of inflammation on lacrimal gland functionExp Eye Res200682588589816309672
  • KrabbeKSPedersenMBruunsgaardHInflammatory mediators in the elderlyExp Gerontol200439568769915130663
  • StevensonWChauhanSKDanaRAn immune-mediated ocular surface disorderArch Ophthalmol201213019010022232476
  • YoshidaNIkedaYNotomiSLaboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosaOphthalmology Epub September 15, 2012
  • Gallego-PinazoRMarsigliaMMrejenSYannuzziLAOuter retinal tubulations in chronic central serous chorioretinopathyGraefes Arch Clin Exp Ophthalmol Epub September 7, 2012
  • GrusFHPodustVNBrunsKSELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eyeInvest Ophthalmol Vis Sci200546386387615728542
  • HiguchiAKawakitaTTsubotaKIL-6 induction in desiccated corneal epithelium in vitro and in vivoMol Vis2011172400240621976951
  • ChoyCKChoPChungWYBenzieIFWater-soluble antioxidants in human tears: effect of the collection methodInvest Ophthalmol Vis Sci200142133130313411726613
  • StevensonWChauhanSKDanaRDry eye disease: an immune-mediated ocular surface disorderArch Ophthalmol201213019010022232476
  • FredmanGSerhanCNSpecialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolutionBiochem J2011437218519721711247
  • SwenorBKBresslerSCaulfieldLWestSKThe impact of fish and shellfish consumption on age-related macular degenerationOphthalmology2010117122395240120630597
  • ChongEWKreisAJWongJYSimpsonJAGuymerRHDietary-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysisArch Ophthalmol2008126682683318541848
  • LicinioJWongMLThe role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotectionMol Psychiatry19994431732710483047
  • RenHMagulikeNGhebremeskelKCrawfordMPrimary open-angle glaucoma patients have reduced levels of blood docosahexaenoic and eicosapentaenoic acidsProstaglandins Leukot Essent Fatty Acids200674315716316410047
  • Pinazo-DuranMDBoscá-GomarLAnti-inflammatory properties of polyunsaturated fatty acid omega 3 Indications in ophthalmologyArch Soc Esp Oftalmol2012877203205 Spanish22732118
  • SapiehaPStahlAChenJ5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acidsSci Transl Med201136969ra12
  • RosenbergESAsbellPAEssential fatty acids in the treatment of dry eyeOcular Surf2010811828
  • LaneSSDuBinerHBEpsteinRJA new system, the LipiFlow, for the treatment of meibomian gland dysfunctionCornea201231439640422222996
  • StewartMThe validity of an interview to assess a patient’s drug takingAm J Prev Med198732951003330658
  • SchiffmanRMChristiansonMDJacobsenGHirschJDReisBLReliability and validity of the Ocular Surface Disease IndexArch Ophthalmol2000118561562110815152
  • SaviniGPrabhawasatPKojimaTGrueterichMEspanaEGotoEThe challenge of dry eye diagnosisClin Ophthalmol200821315519668387
  • BrignoleFPisellaPJGoldschildMDe Saint JeanMGoguelABaudouinCFlow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyesInvest Ophthalmol Vis Sci20004161356136310798650
  • HiguchiAKawakitaTTsubotaKIL-6 induction in desiccated corneal epithelium in vitro and in vivoMol Vis2011172400240621976951
  • Enríquez-de-SalamancaACastellanosESternMETear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye diseaseMol Vis20101686287320508732
  • TuominenISTervoTMTeppoAMValleTUGrönhagen-RiskaCVesaluomaMHHuman tear fluid PDGF-BB, TNF-alpha and TGF-beta1 vs corneal haze and regeneration of corneal epithelium and subbasal nerve plexus after PRKExp Eye Res200172663164111384151
  • BoehmNRiechardtAIWiegandMPfeifferNGrusFHProinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarraysInvest Ophthalmol Vis Sci201152107725773021775656
  • Brignole-BaudouinFBaudouinCAragonaPA multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patientsActa Ophthalmol2011897e591e59721834921
  • Abu El-AsrarAMAl-MansouriSTabbaraKFMissottenLGeboesKImmunopathogenesis of conjunctival remodelling in vernal keratoconjunctivitisEye (Lond)2006201717915746957
  • YooSAKwokSKKimWUProinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic interventionMediators Inflamm2008200812987319223981
  • WangYMaoXOXieLVascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis miceJ Neurosci200727230430717215390
  • RandALAsbellPANutritional supplements for dry eye syndromeCurr Opin Ophthalmol201122427928221597374
  • RonconeMBartlettHEperjesiFEssential fatty acids for dry eye: A reviewCont Lens Anterior Eye2010332495420031476
  • CortinaMSBazanHEDocosahexaenoic acid, protectins and dry eyeCurr Opin Clin Nutr Metab Care201114213213721157308
  • LiNHeJSchwartzCEGjorstrupPBazanHEResolvin E1 improves tear production and decreases inflammation in a dry eye mouse modelJ Ocul Pharmacol Ther201026543143920874497
  • MossSEKleinRKleinBEPrevalence of and risk factors for dry eye syndromeArch Ophthalmol200011891264126810980773
  • LeeAJLeeJSawSMPrevalence and risk factors associated with dry eye symptoms: a population based study in IndonesiaBr J Ophthalmol2002861347135112446361
  • ChiaEMMitchellPRochtchinaELeeAJMarounRWangJJPrevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye StudyClin Experiment Ophthalmol200331322923212786773
  • VisoERodriguez-AresMTGudeFPrevalence of and associated factors for dry eye in a Spanish adult population (the Salnes Eye Study)Ophthalmic Epidemiol2009161152119191177
  • LuoLLiDQDoshiAFarleyWCorralesRMPflugfelderSCExperimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surfaceInvest Ophthalmol Vis Sci200445124293430115557435